Gsa Capital Partners LLP Bristol Myers Squibb CO Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gsa Capital Partners LLP holds 7,671 shares of BMY stock, worth $454,660. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,671

Previous 9,989 23.21%

Holding current value

$454,660

Previous $415,000 4.34%

% of portfolio

0.03%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$39.66 - $51.75 $91,931 - $119,956	-2,318 Reduced 23.21%	7,671 $397,000
Q2 2024 Aug 15, 2024	BUY	$40.25 - $52.99 $402,057 - $529,317	9,989 New	9,989 $415,000
Q4 2023 Feb 16, 2024	BUY	$48.48 - $57.85 $126,047 - $150,410	2,600 Added 4.08%	66,286 $3.4 Million
Q3 2023 Nov 15, 2023	BUY	$57.89 - $64.73 $3.69 Million - $4.12 Million	63,686 New	63,686 $3.7 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $1.82 Million - $2 Million	25,005 Added 860.76%	27,910 $2.15 Million
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $523,317 - $627,504	-8,512 Reduced 74.56%	2,905 $212,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $253,777 - $295,844	4,732 Added 70.79%	11,417 $712,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $395,551 - $463,337	6,685 New	6,685 $396,000
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $572,065 - $831,344	-12,329 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $252,004 - $328,716	-5,121 Reduced 29.35%	12,329 $791,000
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $863,013 - $1.02 Million	-20,178 Reduced 53.62%	17,450 $885,000
Q2 2019 Aug 06, 2019	SELL	$44.62 - $49.34 $171,474 - $189,613	-3,843 Reduced 9.27%	37,628 $1.71 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $964,891 - $1.15 Million	21,385 Added 106.47%	41,471 $1.98 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $1.65 Million - $2.15 Million	-33,927 Reduced 62.81%	20,086 $1.04 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $1.85 Million - $2.09 Million	33,513 Added 163.48%	54,013 $3.35 Million
Q2 2018 Aug 09, 2018	SELL	$50.53 - $62.98 $2.55 Million - $3.18 Million	-50,564 Reduced 71.15%	20,500 $1.13 Million
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $148,841 - $171,346	2,484 Added 3.62%	71,064 $4.5 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $3.53 Million - $3.85 Million	58,842 Added 604.25%	68,580 $4.2 Million
Q3 2017 Nov 20, 2017	BUY	$55.23 - $63.74 $537,829 - $620,700	9,738	9,738 $621,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Bristol Myers Squibb CO Transaction History